FDA Inspection
Element Materials Technology Boston - Acton Inc.Element Materials Technology Boston - Acton Inc. – FDA Inspection, Nov 10, 2011
Record Details
This FDA Inspection record concerns Element Materials Technology Boston - Acton Inc., with an inspection on November 10, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 10, 2011
- Product Type
- Drugs
View Company Profile
ID · 29a8aa86-a31a-4404-9c80-f3dc1d7662eb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 752926
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Element Materials Technology Boston - Acton Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 4, 2026 | VAI | New England District Office | Drug Quality Assurance |
| August 1, 2025 | Not classified | New England District Office | Human Cellular, Tissue, and Gene Therapies |
| January 15, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Element Materials Technology Boston - Acton Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.